179239-88-4 Usage
Structure
A pyrimidine ring with a furan ring attached to the 1-position, and an amino group attached to the 4-position.
Type
A heterocyclic compound
Biological activity
Has potential biological activities and pharmacological properties.
Uses
Can be used as an intermediate in the synthesis of pharmaceuticals and agrochemicals.
Safety
Should be handled with care and safety protocols should be followed when working with it in a laboratory setting.
Nomenclature
The name 2(1H)-Pyrimidinone, 4-amino-1-(tetrahydro-3,4-dihydroxy-2-furanyl)-, [2S-(2alpha,3ba,4ba)](9CI) describes the compound's structure and stereochemistry, indicating the presence of a pyrimidinone ring, a furan ring, and an amino group, as well as the stereochemistry of the compound.
Check Digit Verification of cas no
The CAS Registry Mumber 179239-88-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,2,3 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 179239-88:
(8*1)+(7*7)+(6*9)+(5*2)+(4*3)+(3*9)+(2*8)+(1*8)=184
184 % 10 = 4
So 179239-88-4 is a valid CAS Registry Number.
179239-88-4Relevant articles and documents
(13C)-Substituted Erythronucleosides: Synthesis and Conformational Analysis by 1H and 13C NMR Spectroscopy
Kline, Paul C.,Serianni, Anthony S.
, p. 1772 - 1777 (2007/10/02)
The erythronucleosides, 9-β-D-erythrofuranosyladenine (1b), 1-β-D-erythrofuranosylcytosine (2b), 9-β-D-erythrofuranosylguanine (3b), and 1-β-D-erythrofuranosyluracil (4b), were synthesized with and without 13C-substitution at C1' of the furanose ring. 75-
